Diagnostic Performance of PET/CT and Bone Scintigraphy in Breast Cance Patients with Suspected Bone Metastasis

Diagnostic Performance of PET/CT and Bone Scintigraphy in Breast Cance Patients with Suspected Bone Metastasis - Diagnostic Performance of PET/CT and Bone Scintigraphy in Breast Cance Patients with Suspected Bone Metastasis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006003

Enrollment

Registered

2011-07-20

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

PET/CT

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Age 20-75 Patient had breast cancer ECOG PS0-1 Localized symptoms Elevated alkaline phosphatase Elevated tumor marker Patients with bone metastases suspected by bone scintigraphy

Exclusion criteria

Exclusion criteria: Prior diagnosed bone metastases from breast cancer ECOG PS0-1 Pre-existing pulmonary and/or cardiac disease Pre-existing ascites and pleural effusion. Pre-existing infection disease Patient have drug allergy Pre-existing mental disorder Prior autologous bone marrow transplantation Pre-existing brain metastasis History of any other cancer (except no-invasive cancer) Pregnant or sexually active women not using reliable contraception

Design outcomes

Primary

Measure	Time frame
sensitivity and specificity	—

Countries

Japan

Contacts

Public ContactNaoki Niikura

Tokai University school of medicine Department Breast and Endocrine Surgery

niikura@is.icc.u-tokai.ac.jp1463931121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026